House Report Says High Drug Prices Are ‘Unsustainable,’ Urges Passage of Build Back Better

In a 269-page report released Friday, the House Committee on Oversight and Reform challenges claims that high prescription drug prices are necessary to support innovation and details a slew of anticompetitive practices drugmakers have allegedly used in recent years.
Source: Drug Industry Daily